APA

Murakami K., Suzuki M., Suzuki N., Hamajo K., Tsukamoto T. & Shimojo M. (20131023). Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats. : Brain research.

Chicago

Murakami Koji, Suzuki Motohisa, Suzuki Noriko, Hamajo Kazuhiro, Tsukamoto Tetsuya and Shimojo Masato. 20131023. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats. : Brain research.

Harvard

Murakami K., Suzuki M., Suzuki N., Hamajo K., Tsukamoto T. and Shimojo M. (20131023). Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats. : Brain research.

MLA

Murakami Koji, Suzuki Motohisa, Suzuki Noriko, Hamajo Kazuhiro, Tsukamoto Tetsuya and Shimojo Masato. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats. : Brain research. 20131023.